Equalize 2020 Pitch Presenters Announced

Equalize 2020 Image

Twelve finalists were selected from 57 applicants. Equalize 2020 will run two, parallel pitch sessions: Diagnostics & Medical Devices and Therapeutics. 

>> Download flyer (.pdf)

Diagnostics & Medical Devices Session

Reetuparna Das
University of Michigan
Startup: Sequal
Technology:Ultra-rapid molecular diagnosis of cancer

Melanie Joy
University of Colorado
Startup:
Katharos, Inc.
Technology:
Extracorporeal device for optimizing
phosphate control in hemodialysis

Sunyoung Kim
Louisiana State University School of Medicine & Health Sciences Center
Startup: Chosen Diagnostics Inc.
Technology: Biomarker panel to improve
necrotizing enterocolitis diagnosis

Kacey Marra
University of Pittsburgh
Startup: AxoMax Technologies, Inc.
Technology: Biodegradable nerve guide

Sarah Vigmostad
The University of Iowa
Startup: SynderBio, Inc.
Technology: Novel, high-throughput cell separation
techniques for single cell sequencing and cancer diagnosis

Pamela Woodard
Washington University in St. Louis
Startup: GwynTech
Technology: AtheroBrite

Therapeutics Session 


Alexis Demonbreun
Northwestern University
Startup:
Ikaika Therapeutics
Technology:
Genetic modifiers of muscle disease
as therapeutic targets

Barbara Ehrlich
Yale University
Startup: Center Pharm
Technology: A new target for treatment of
Wolfram Syndrome

Yiping Han
Columbia University
Technology: Novel therapeutics to treat
familial adenomatous polyposis (FAP)

Sandhya Kortagere
Drexel University
Technology: A disease modifying and neuroprotective
agent to treat Parkinson’s disease

Martina Roos
University of California, Los Angeles
Startup: Sardona Therapeutics
Technology: Small molecules targeting RNA regulators in cancer stem cells

Judith Sebolt-Leopold
University of Michigan
Startup: Mekanistic Therapeutics
Technology: A first-in-class therapeutic targeting
deregulation of EGFR and PI3K

Leave a Reply